Cannvas Sponsors Pancreatic Cancer Fundraiser in Montreal
Lip Sync Battles Cancer Hosts its Third Event
TORONTO, Oct. 1, 2018 /CNW/ – Cannvas MedTech Inc. (“Cannvas” or the “Company”) (CSE: MTEC) (Frankfurt: 3CM), a leading business technology company in the cannabis space, is pleased to announce it is partnering with Lip Sync Battles Cancer in support of Pancreatic Cancer Canada to sponsor the third annual Lip Sync Battles Cancer fundraiser in Montreal, QC.
“We are pleased to partner with Lip Sync Battles and Pancreatic Cancer Canada for this very special event in Montreal,” said Daniel Davidzon, Marketing Manager, Cannvas MedTech Inc. “Many of us have been touched by cancer in one way or another, and pancreatic cancer has among the toughest prognoses even with early detection. As advocates of medical cannabis as an alternative health care option, our goal and the focus of our Cannvas.Me online portal is to educate the general public on the benefits of using medical cannabis. I look forward to a successful event and working more with Pancreatic Cancer Canada.”
This year’s event will take place on Saturday, November 24 starting at 7pm at the Phi Centre, a meticulously restored heritage building located at 407 Rue Saint-Pierre in Old Montreal. It will be hosted by Michael Musi, a Montreal-born-and-raised actor who can be found playing Terence on the hit CBC show “Kim’s Convenience”.
“We are grateful for all the support we have received for this year’s Lip Sync Battles from Cannvas MedTech and are thrilled to partner with an educational platform that can help provide cancer patients with potential forms of pain relief and management,” said Marianne Musi, co-founder, Lip Sync Battles. “Our goal has always been to support Pancreatic Cancer Canada and the greater medical community in their quest to eradicate cancer in all its forms while providing friends and families of pancreatic cancer patients an outlet to have fun, celebrate life and show their love for friends and family.”
About Lip Sync Battles
Lip Sync Battles Cancer was born three years ago when co-founders Marianne Musi and Vince Colletti decided to have a get-together with friends and host a Lip Sync Battle. The idea flourished into a fundraising event where all proceeds go to Pancreatic Cancer Canada. Michael and Marianne Musi are extremely passionate about raising funds for pancreatic cancer since it took their 52-year-old mother a little over five years ago. Event Details: https://www.facebook.com/events/393570737841946/
About Pancreatic Cancer Canada
Pancreatic Cancer Canada is the only national organization devoted to fighting pancreatic cancer through research, awareness, education and advocacy. Our goals are to improve overall patient survival rates, change the outcomes and create a brighter future for those affected by pancreatic cancer. For more information about the Pancreatic Cancer Canada Foundation: PancreaticCancerCanada.ca
About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.
SOURCE Cannvas MedTech Inc.
For further information: www.cannvasmedtech.com; Media Inquiries, firstname.lastname@example.org; Investor Relations, email@example.com, 1-800-489-0116